Literature DB >> 11152580

HIV-Specific CD4(+) and CD8(+) immune responses are generated with a gp120-depleted, whole-killed HIV-1 immunogen with CpG immunostimulatory sequences of DNA.

R B Moss1, J Diveley, F C Jensen, E Gouveia, J Savary, D J Carlo.   

Abstract

We examined the adjuvant effects of a synthetic CpG oligodeoxynucleotide immunostimulatory sequence (ISS) using a whole-killed, gp120-depleted HIV antigen (HIV-1 antigen) in a Lewis rat model. We hypothesized that HIV-1-specific CD4(+) T helper (Th) immune responses could be enhanced when an ISS was combined with an HIV-1 antigen in incomplete Freund's adjuvant (IFA). We also reasoned that if such Th responses were sufficient, such a combination might also induce HIV-specific CD8(+) T cell immune responses. Here we demonstrate that the HIV-1 antigen in IFA combined with ISS stimulates both CD4(+) and CD8(+) HIV-specific immune responses as measured by interferon-gamma (IFN-gamma) in the ELISPOT assay. A strong correlation between these CD4(+) and CD8(+) responses was demonstrated. Furthermore, we found that the HIV-1 antigen in IFA with ISS as an adjuvant stimulated strong antibody responses to core antigen (p24). These studies suggest that the combination of the whole-killed, gp120-depleted HIV-1 antigen in IFA with ISS may be an ideal candidate to test in nonhuman primates and in human studies as a preventive HIV-1 vaccine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11152580     DOI: 10.1089/107999000750053807

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  2 in total

1.  Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent model.

Authors:  Ronald B Moss; Jay R Savary; Jocelyn P Diveley; Fred Jensen; Dennis J Carlo
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

2.  Optimal thawing of cryopreserved peripheral blood mononuclear cells for use in high-throughput human immune monitoring studies.

Authors:  Hari Ramachandran; Jessica Laux; Ioana Moldovan; Richard Caspell; Paul V Lehmann; Ramu A Subbramanian
Journal:  Cells       Date:  2012-07-25       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.